Low detection limit (2 μM), tumor size less than 0.25 mM detectable and superior imaging quality, high sensitivity, less dosage, less metal toxicity, dual imaging capacity

About

Contrast Agents: Methods of Preparing and Methods of Imaging

Inventor

Binghe Wang

IP Status

Patent pending

GSU Case Number

2011-11

Introduction

Early diagnostics for tumor metastasis in liver are highly desirable for cancer prognosis and treatment. There is a strong need to develop MRI contrast agents with high sensitivity, high safety profile, optimized blood retention time and biomarker targeting capability for tumor diagnosis. For liver metastasis, current imaging techniques can detect lesions up to 1-2 cm in size. Surgical procedures are needed to detect millimeter sized lesions. Diagnosing metastatic cancer down to 1-2 mm in size has the potential for immense improvement in cancer detection and treatment.

Technology

Researchers at Georgia State University have developed a novel and highly efficient class of MRI contrast agents. They designed and obtained mutated protein contrast agents with high Gd3+ binding affinity and relaxivity. These novel contrast agents have a detection limit of 2 μM, 15 times lower than clinical MRI contrast agents and require a dosage 60 times lower (0.0033 mmol/kg) than Magnevist. Using these contrast agents, liver metastasis has been detected with a tumor size less than 0.25 mm. This improvement in diagnostic accuracy and efficacy make it applicable for imaging tumor metastasis demonstrated in liver, kidney and blood vessels.

Applications


Imaging millimeter sized metastatic tumor lesions
Cancer diagnostic


Advantages


Low detection limit (2 μM), tumor size less than 0.25 mM detectable
Superior imaging quality, high sensitivity, less dosage, less metal toxicity, dual imaging capacity
Improved accuracy and specificity of tumor detection
Excellent safety profile and pharmacokinetics
No observed toxicity


 

Purchase a license for full unlimited access to all innovation profiles on LEO

  • Direct connection to thousands of more innovations
  • Access to market Experts and Universities
  • Filter relevant solutions into your own dedicated Network